参考文献/References:
[1] 唐志锋,李 姝.Lugol氏液-美蓝双重染色诊断早期食管癌的临床价值[J].中国急救复苏与灾害医学杂志,2007,2(10):589-590,599.
[2] 杜兴龙,徐元肃,魏 洁.胸苷激酶1对进展期食管鳞癌放疗的影响[J].中华全科医学,2018,16(5):732-735.
[3] Chen W,Zheng R,Baade PD,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132.
[4] 郝兆星.浅表型食管癌的临床及病理分析[J].中华全科医学,2014,12(2):234-235.
[5] Santillan AA,Farma JM,Meredith KL,et al. Minimally invasive surgery for esophageal cancer[J]. J Natl Compr Canc Netw,2008,6(9):879-884.
[6] Ruhstaller T,Pless M,Dietrich D,et al. Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable,locally advanced esophageal carcinoma:a prospective,multicenter phase IB/II Trial(SAKK 75/06)[J]. J Clin Oncol,2011,29(6):626-631.
[7] Ribas A,Hamid O,Daud A,et al. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma[J]. JAMA,2016,315(15):1600-1609.
[8] Miller KD,Nogueira L,Mariotto AB,et al. Cancer treatment and survivorship statistics,2019[J]. CA Cancer J Clin,2019,69(5):363-385.
[9] Zhu JF,Feng XY,Zhang XW,et al. Time distribution of recurrence risk of oesophageal squamous cell carcinoma with complete resection(R0)in a Chinese population[J]. Eur J Cardiothorac Surg,2015,48(6):899-905.
[10] Fang W. Interpretation of 2017 National Comprehensive Cancer Network(NCCN)guidelines for the diagnosis and treatment of esophageal squamous cell carcinoma through the new TNM staging of esophageal carcinoma(eighth edition)by the Union for International Cancer Control(UICC)and the American Cancer Commission(AJCC)[J]. Zhonghua Wei Chang Wai Ke Za Zhi,2017,20(10):1122-1126.
[11] Kim I,Kim HG,Kim H,et al.Hepatic expression,synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis[J]. Biochem J,2000,346:603-610.
[12] Zheng S,Shen J,Jiao Y,et al. Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity[J]. Cancer Sci,2009,100(5):859-865.
[13] Ding P,Zheng C,Cao G,et al. Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I-II gastric cancer after curative gastrectomy[J]. Cancer Med,2019,8(6):2919-2929.
[14] Ilhan-Mutlu A,Starlinger P,Perkmann T,et al. Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer[J]. Biomark Med,2015,9(4):327-335.
[15] Zhang SS,Lei YY,Cai XL,et al. Preoperative serum fibrinogen is an independent prognostic factor in operable esophageal cancer[J]. Oncotarget,2016,7(18):25461-25469.
[16] Matsuda S,Takeuchi H,Kawakubo H,et al. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy:comparison with the Glasgow prognostic score[J]. Ann Surg Oncol,2015,22(1):302-310.
[17] Li XH,Wang XP,Gu WS,et al. Clinical significance of preoperative thrombin time in patients with esophageal squamous cell carcinoma following surgical resection[J]. PLoS One,2015,10(10):e140323.
[18] Hong T,Shen D,Chen X,et al. Preoperative plasma fibrinogen,but not D-dimer might represent a prognostic factor in non-metastatic colorectal cancer:a prospective cohort study[J]. Cancer Biomark,2017,19(1):103-111.
[19] Sahni A,Khorana AA,Baggs RB,et al. FGF-2 binding to fibrin(ogen)is required for augmented angiogenesis[J]. Blood,2006,107(1):126-131.
[20] Witsch E,Sela M,Yarden Y.Roles for growth factors in cancer progression[J]. Physiology(Bethesda),2010,25(2):85-101.
[21] Shu YJ,Weng H,Bao RF,et al.Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection:a retrospective and in vitro study[J]. BMC Cancer,2014,14:566.
[22] Staton CA,Brown NJ,Lewis CE.The role of fibrinogen and related fragments in tumour angiogenesis and metastasis[J]. Expert Opin Biol Ther,2003,3(7):1105-1120.
[23] Wayman J,O'Hanlon D,Hayes N,et al. Fibrinogen levels correlate with stage of disease in patients with oesophageal cancer[J]. Br J Surg,1997,84(2):185-188.(收稿:2020-01-12)
相似文献/References:
[1]童 真,张世达△.无充气经腋窝入路腔镜手术治疗早期甲状腺肿瘤疗效及对患者免疫功能和美学效果的影响[J].陕西医学杂志,2020,49(11):1422.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.013]
TONG Zhen,ZHANG Shida..Efficacy of non-inflatable transaxillary approach laparoscopic surgery in treatment of early thyroid neoplasms and its effect on immune function and aesthetic effect[J].,2020,49(5):1422.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.013]
[2]张利丽,耿利娜,李佳娜,等.Stanford A型主动脉夹层术后并发症发生率Meta分析[J].陕西医学杂志,2022,51(11):1453.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.032]
ZHANG Lili,GENG Lina,LI Jiana,et al.Meta-analysis of incidence of postoperative complications in Stanford type A aortic dissection[J].,2022,51(5):1453.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.032]
[3]高海聪,张永锋,张小军,等.自制椎弓根定位器辅助下关节突外侧入路脊柱内镜技术临床应用研究[J].陕西医学杂志,2023,52(8):1019.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.017]
[4]马西淼,华永永,邱琼香,等.食管鳞癌组织中c-myc、神经鞘胚素表达及其与患者临床病理特征和预后关系研究[J].陕西医学杂志,2023,52(9):1254.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.033]
MA Ximiao,HUA Yongyong,QIU Qiongxiang,et al.Expressions of c-myc and Artemin in esophageal squamous cell carcinoma tissues and their relationship with clinicopathological features and prognosis of patients[J].,2023,52(5):1254.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.033]
[5]包鑫鑫,马 月,朱雅婷,等.基于脂质代谢相关基因的食管鳞癌预后预测模型构建及体外细胞实验验证[J].陕西医学杂志,2024,(12):1587.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.001]
BAO Xinxin,MA Yue,ZHU Yating,et al.Construction of prognostic prediction model for esophageal squamous carcinoma based on lipid metabolism-related genes and validation in vitro cell experiment[J].,2024,(5):1587.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.001]